Search - tctmd.com

Displaying 241 - 260 of 576

Sort: Relevancy | Date

News Industry News

JENAVALVE ANNOUNCES FIRST IMPLANTATION OF TRANSAPICAL TAVI SYSTEM IN SWEDEN

June 04, 2014

News Industry News

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

June 04, 2014

News Industry News

Transcatheter Technologies receives Second tranche of Series B cash infusion

June 02, 2014

News Conference News EuroPCR 2014

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

Caitlin E. Cox

May 23, 2014

News Conference News EuroPCR 2014

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

L.A. McKeown

May 23, 2014

News Industry News

PRIMARY ENDPOINT DATA PRESENTED ON PERFORMANCE AND SAFETY OF THE JENAVALVE TAVI SYSTEM

May 21, 2014

News Industry News

Medtronic CoreValve® System Demonstrates Positive Clinical Performance at Two Years in 'Real World' ADVANCE Study

May 21, 2014

News Industry News

Boston Scientific Lotus™ Valve System Demonstrates Strong Performance And Safety Profile At Six Months

May 21, 2014

News Industry News

Excellent Early Experience Reported With Edwards SAPIEN 3 Transcatheter Valve

May 20, 2014

News Daily News

A-fib, Dialysis Dramatically Worsen Outlook for TAVR Patients with Advanced CKD

May 07, 2014

News Daily News

CT-Based Artery Assessment May Reduce Vascular Complications in Transfemoral TAVR

L.A. McKeown

May 06, 2014

News Daily News

FRANCE 2 Registry Yields Early Mortality Risk Score for TAVR

April 24, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Conference News ACC 2014

TAVR With the CoreValve Device Superior to Surgery at 1 Year

Yael L. Maxwell

March 29, 2014

News Conference News ACC 2014

Depth, Cusp Stretching Linked to Need for Pacemaker after TAVR

L.A. McKeown

March 29, 2014

News Daily News

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

March 20, 2014

News Daily News

CoreValve Reduce la Mortalidad al cabo de 1 Año en Pacientes de Riesgo Quirúrgico Extremo

March 20, 2014

News Daily News

Patients with Severe Pulmonary Hypertension Benefit from TAVR Despite Increased Mortality

L.A. McKeown

March 13, 2014

News Daily News

Los Pacientes con Hipertensión Pulmonar Severa se Benefician de la TAVR a pesar de una Mayor Mortalidad

L.A. McKeown

March 13, 2014

News Daily News

La EPOC es Común en Pacientes TAVR y se Asocia a una Mayor Mortalidad CV

Jason Kahn

March 06, 2014

Advertisement

JENAVALVE ANNOUNCES FIRST IMPLANTATION OF TRANSAPICAL TAVI SYSTEM IN SWEDEN

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

Transcatheter Technologies receives Second tranche of Series B cash infusion

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

PRIMARY ENDPOINT DATA PRESENTED ON PERFORMANCE AND SAFETY OF THE JENAVALVE TAVI SYSTEM

Medtronic CoreValve® System Demonstrates Positive Clinical Performance at Two Years in 'Real World' ADVANCE Study

Boston Scientific Lotus™ Valve System Demonstrates Strong Performance And Safety Profile At Six Months

Excellent Early Experience Reported With Edwards SAPIEN 3 Transcatheter Valve

A-fib, Dialysis Dramatically Worsen Outlook for TAVR Patients with Advanced CKD

CT-Based Artery Assessment May Reduce Vascular Complications in Transfemoral TAVR

FRANCE 2 Registry Yields Early Mortality Risk Score for TAVR

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

TAVR With the CoreValve Device Superior to Surgery at 1 Year

Depth, Cusp Stretching Linked to Need for Pacemaker after TAVR

CoreValve Reduces Mortality at 1 Year in Patients at Extreme Surgical Risk

CoreValve Reduce la Mortalidad al cabo de 1 Año en Pacientes de Riesgo Quirúrgico Extremo

Patients with Severe Pulmonary Hypertension Benefit from TAVR Despite Increased Mortality

Los Pacientes con Hipertensión Pulmonar Severa se Benefician de la TAVR a pesar de una Mayor Mortalidad

La EPOC es Común en Pacientes TAVR y se Asocia a una Mayor Mortalidad CV

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content